Lakeshore Biopharma Co.LSBCF
13F holders, Q1 2025 (March 31)9holders +3
3new positions
0sold out
1famous investor
$0.70avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Lakeshore Biopharma Co. Ltd. (LSBCF) in their 13F filings, up 3 from Q4 2024. 3 opened new positions and 0 sold out. The largest holders were Orbimed Advisors LLC ($344K), FMR LLC ($282K) and HHLR Advisors, LTD. ($182K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $69K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,059,246 shares bought, net +1,059,246 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Orbimed Advisors LLC | 0.01% | No change | 140,428 | $344K |
| FMR LLC | 0.00% | No change | 116,508 | $282K |
| HHLR Advisors, LTD. | 0.01% | No change | 75,179 | $182K |
| Superstring Capital Management LP | 0.09% | No change | 30,792 | $75K |
| Barclays PLC | 0.00% | No change | 24,757 | $61K |
| Toronto Dominion Bank | 0.00% | New | 1,048,320 | $43K |
| Citadel Advisors | 0.00% | New | 10,586 | $26K |
| UBS Group AG | 0.00% | Add +6.4% | 1,000 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 280 | $686 |
"% of holder's portfolio" is LSBCF's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.